col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Biochemical and Biophysical Research Communications
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―15 SARS-CoV-2 triggers DNA damage response in Vero E6 cells Joshua Victor, Jamie Deutsch, Annalis Whitaker, Erica N. Lamkin, Anthony March, Pei Zhou, et al. (+2)
2 [GO] 2021―Sep―13 The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, Sun-Je Woo, Min-Ho Lee, Patricia M. Nuijten, et al. (+16)
3 [GO] 2021―Sep―08 Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, et al. (+6)
4 [GO] 2021―Aug―23 Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria Youichi Suzuki, Takayuki Hishiki, Akino Emi, Shoichi Sakaguchi, Ronko Itamura, Rain Yamamoto, et al. (+5)
5 [GO] 2021―Aug―15 A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17 Eamonn F. Healy, Marko Lilic
6 [GO] 2021―Aug―15 Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain
7 [GO] 2021―Jul―20 A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding Yingyi Long, Shuyi Song, Feiyang Luo, Xiaojian Han, Chao Hu, Yingming Wang, et al. (+6)
8 [GO] 2021―Jul―16 Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight Feroza Begum, Amit Kumar Srivastava, Upasana Ray
9 [GO] 2021―Jul―13 Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro Mami Oba, Wen Rongduo, Akatsuki Saito, Tamaki Okabayashi, Tomoko Yokota, Junko Yasuoka, et al. (+5)
10 [GO] 2021―Jul―02 Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins Samanta Del Veliz, Lautaro Rivera, Diego M. Bustos, Marina Uhart
11 [GO] 2021―Jun―10 Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method Kevin Maafu Juma, Teisuke Takita, Kenji Ito, Masaya Yamagata, Shihomi Akagi, Emi Arikawa, et al. (+6)
12 [GO] 2021―Jun―07 Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant Dong-Kyun Ryu, Rina Song, Minsoo Kim, Young-Il Kim, Cheolmin Kim, Jong-In Kim, et al. (+10)
13 [GO] 2021―Jun―05 Analysis of the molecular mechanism of SARS-CoV-2 antibodies Dongfu Jin, Jing Wei, Jian Sun
14 [GO] 2021―May―29 Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein Ryan Yuki Huang, Deron Raymond Herr
15 [GO] 2021―May―26 Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant Shinya Ohki, Tomohiro Imamura, Yasuki Higashimura, Kenji Matsumoto, Masashi Mori
16 [GO] 2021―May―21 Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective Ibrahim M. Ibrahim, Abdo A. Elfiky, Alaa M. Elgohary
17 [GO] 2021―May―11 SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence Olena Kalashnyk, Olena Lykhmus, Mykhailo Izmailov, Lyudmyla Koval, Serhiy Komisarenko, Maryna Skok
18 [GO] 2021―Apr―21 Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197 Bellone Maria Laura, Puglisi Andrea, Dal Piaz Fabrizio, Hochkoeppler Alejandro
19 [GO] 2021―Apr―08 In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5 Dai Hatakeyama, Takeshi Masuda, Ryosuke Miki, Sumio Ohtsuki, Takashi Kuzuhara
20 [GO] 2021―Mar―26 ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jerome Deval, et al. (+18)
21 [GO] 2021―Mar―26 Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation Aditya K. Padhi, Timir Tripathi
22 [GO] 2021―Mar―24 SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration Danish Idress, Vijay Kumar
23 [GO] 2021―Mar―19 A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs Yue Zhang, Guanglin Niu, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski
24 [GO] 2021―Mar―15 A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 Robert L. Kruse, Yuting Huang, Heather Smetana, Eric A. Gehrie, Tim K. Amukele, Aaron A.R. Tobian, et al. (+2)
25 [GO] 2021―Feb―26 SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring Filipe Pereira
26 [GO] 2021―Feb―15 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
27 [GO] 2021―Feb―13 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
28 [GO] 2021―Feb―10 EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro Minsu Jang, Rackhyun Park, Yea-In Park, Yeo-Eun Cha, Ayane Yamamoto, Jin I. Lee, Junsoo Park
29 [GO] 2021―Feb―04 H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine Eduardo Alfredo Adami, Stefanni Liliane Chavez Rico, Milena Apetito Akamatsu, Cosue Miyaki, Isaías Raw, Dourival de Oliveira, et al. (+8)
30 [GO] 2021―Jan―29 5-amino levulinic acid inhibits SARS-CoV-2 infection Yasuteru Sakurai, Mya Myat Ngwe Tun, Yohei Kurosaki, Takaya Sakura, Daniel Ken Inaoka, Kiyotaka Fujine, et al. (+3)
31 [GO] 2021―Jan―22 The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients Veronique A.J. Smits, Esperanza Hernández-Carralero, María Cristina Paz-Cabrera, Elisa Cabrera, Yeray Hernández-Reyes, Juan Ramón Hernández-Fernaud, et al. (+4)
32 [GO] 2021―Jan―15 ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain Mei Dang, Yifan Li, Jianxing Song
33 [GO] 2021―Jan―15 RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif Ali H. Aldhumani, Md Ismail Hossain, Emily A. Fairchild, Hannah Boesger, Emily C. Marino, Mason Myers, Jennifer V. Hines
34 [GO] 2021―Jan―10 Nonlinear adaptive control of COVID-19 with media campaigns and treatment Boqiang Cao, Ting Kang
35 [GO] 2021―Jan―08 The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy Yasir Mohamud, Yuan Chao Xue, Huitao Liu, Chen Seng Ng, Amirhossein Bahreyni, Eric Jan, Honglin Luo
36 [GO] 2021―Jan―06 The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease Wei-Chung Chiou, Jui-Chieh Chen, Jinn-Moon Yang, Lih-Hwa Hwang, Yi-Shuan Lyu, Hsin-Yi Yang, Cheng Huang
37 [GO] 2021―Jan―01 Pathogenesis of COVID-19 and the quality control of nucleic acid detection Xiao-Dong Mao, Taiping Li, Zhirong Xu, Kangsheng Liu
38 [GO] 2020―Dec―26 In silico study of the potential interactions of 4′-acetamidechalcones with protein targets in SARS-CoV-2 Francisco Wagner Q. Almeida-Neto, Maria Geysillene Castro Matos, Emanuelle M. Marinho, Márcia M. Marinho, Ramon R.P.P.B. de Menezes, Tiago L. Sampaio, et al. (+6)
39 [GO] 2020―Dec―24 Comprehensive analysis of COVID-19 during pregnancy Kathryn M. Moore, Mehul S. Suthar
40 [GO] 2020―Dec―13 Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex Koki Kato, Dini Kurnia Ikliptikawati, Akiko Kobayashi, Hiroya Kondo, Keesiang Lim, Masaharu Hazawa, Richard W. Wong
41 [GO] 2020―Dec―09 Range of reproduction number estimates for COVID-19 spread Damiano Pasetto, Joseph C. Lemaitre, Enrico Bertuzzo, Marino Gatto, Andrea Rinaldo
42 [GO] 2020―Dec―05 A perspective on early detection systems models for COVID-19 spreading Chiara Vianello, Fernanda Strozzi, Paolo Mocellin, Elisa Cimetta, Bruno Fabiano, Flavio Manenti, et al. (+2)
43 [GO] 2020―Dec―03 Identification of antiviral antihistamines for COVID-19 repurposing Leah R. Reznikov, Michael H. Norris, Rohit Vashisht, Andrew P. Bluhm, Danmeng Li, Yan-Shin J. Liao, et al. (+3)
44 [GO] 2020―Nov―28 Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors Daoqun Li, Junwen Luan, Leiliang Zhang
45 [GO] 2020―Nov―28 The biogenesis of SARS-CoV-2 spike glycoprotein: Multiple targets for host-directed antiviral therapy Silvia Santopolo, Anna Riccio, M. Gabriella Santoro
46 [GO] 2020―Nov―28 Structural stability of SARS-CoV-2 virus like particles degrades with temperature A. Sharma, B. Preece, H. Swann, X. Fan, R.J. McKenney, K.M. Ori-McKenney, et al. (+2)
47 [GO] 2020―Nov―28 Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Cristina Mussini
48 [GO] 2020―Nov―28 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
49 [GO] 2020―Nov―21 The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 Zhenming Jin, Haofeng Wang, Yinkai Duan, Haitao Yang
50 [GO] 2020―Nov―20 Remdesivir: From Ebola to COVID-19 M. Gabriella Santoro, Ernesto Carafoli
51 [GO] 2020―Nov―20 Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches Koichi Watashi
52 [GO] 2020―Nov―20 Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics Martin A. Walsh, Jonathan M. Grimes, David I. Stuart
53 [GO] 2020―Nov―20 Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation Airi Rump, Robert Risti, Mai-Ly Kristal, Jekaterina Reut, Vitali Syritski, Aivar Lookene, Sirje Ruutel Boudinot
54 [GO] 2020―Nov―17 Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2 Marcelo A. Lima, Mark Skidmore, Farhat Khanim, Alan Richardson
55 [GO] 2020―Nov―17 Vaccine-induced protection in aging adults and pandemic response Theodore Schenkelberg
56 [GO] 2020―Nov―13 A nidovirus perspective on SARS-CoV-2 Anastasia A. Gulyaeva, Alexander E. Gorbalenya
57 [GO] 2020―Nov―13 Functional importance of the D614G mutation in the SARS-CoV-2 spike protein Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe
58 [GO] 2020―Nov―11 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
59 [GO] 2020―Nov―07 T-cell dysregulation in COVID-19 Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono
60 [GO] 2020―Nov―07 Proactive and blended approach for COVID-19 control in Taiwan Hao-Yuan Cheng, Angela Song-En Huang
61 [GO] 2020―Nov―07 Biochemical and Biophysical Research Communications History of the COVID-19 pandemic: Origin, explosion, worldwide spreading Sara Platto, Yanqing Wang, Jinfeng Zhou, Ernesto Carafoli
62 [GO] 2020―Nov―07 Evolution patterns of SARS-CoV-2: Snapshot on its genome variants Marta Giovanetti, Francesca Benedetti, Giovanni Campisi, Alessandra Ciccozzi, Silvia Fabris, Giancarlo Ceccarelli, et al. (+5)
63 [GO] 2020―Nov―07 Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity Jorge Carrillo, Nuria Izquierdo-Useros, Carlos Ávila-Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco
64 [GO] 2020―Nov―05 Host-directed editing of the SARS-CoV-2 genome Tobias Mourier, Mukhtar Sadykov, Michael J. Carr, Gabriel Gonzalez, William W. Hall, Arnab Pain
65 [GO] 2020―Nov―05 The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design Danielle C. Groves, Sarah L. Rowland-Jones, Adrienn Angyal
66 [GO] 2020―Nov―02 Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19 Dylan C. Sarver, G. William Wong
67 [GO] 2020―Oct―28 Laboratory testing for the diagnosis of COVID-19 Christopher Koon Chi Lai, Wilson Lam
68 [GO] 2020―Oct―26 Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives Cheryl Baxter, Quarraisha Abdool Karim, Salim S. Abdool Karim
69 [GO] 2020―Oct―23 T cell immunity to SARS-CoV-2 following natural infection and vaccination Anthony T. DiPiazza, Barney S. Graham, Tracy J. Ruckwardt
70 [GO] 2020―Oct―21 Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 Luca Zinzula
71 [GO] 2020―Oct―21 The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2? David A. Jans, Kylie M. Wagstaff
72 [GO] 2020―Oct―16 Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease Sara Platto, Jinfeng Zhou, Yanqing Wang, Huo Wang, Ernesto Carafoli
73 [GO] 2020―Oct―10 Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 Jacques Fantini, Henri Chahinian, Nouara Yahi
74 [GO] 2020―Oct―10 Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies Meng Yuan, Hejun Liu, Nicholas C. Wu, Ian A. Wilson
75 [GO] 2020―Oct―03 High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 Luca Zinzula, Jerome Basquin, Stefan Bohn, Florian Beck, Sven Klumpe, Günter Pfeifer, et al. (+4)
76 [GO] 2020―Sep―30 Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection Ernesto Carafoli
77 [GO] 2020―Sep―18 Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone Kiril Kuzmin, Ayotomiwa Ezekiel Adeniyi, Arthur Kevin DaSouza, Deuk Lim, Huyen Nguyen, Nuria Ramirez Molina, et al. (+3)
78 [GO] 2020―Sep―14 The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues Jialu Qiao, Weiling Li, Jian Bao, Qian Peng, Dongmei Wen, Jianing Wang, Binlian Sun
79 [GO] 2020―Sep―11 Potent antiviral effect of silver nanoparticles on SARS-CoV-2 Sundararaj S. Jeremiah, Kei Miyakawa, Takeshi Morita, Yutaro Yamaoka, Akihide Ryo
80 [GO] 2020―Sep―04 RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19 Yi Jiang, Wanchao Yin, H. Eric Xu
81 [GO] 2020―Aug―25 Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage Tzu-Hau Shi, Yi-Long Huang, Chiao-Che Chen, Wen-Chieh Pi, Yu-Ling Hsu, Lee-Chiang Lo, et al. (+3)
82 [GO] 2020―Aug―15 Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 H.Y. Lim Tung, Pierre Limtung
83 [GO] 2020―Jul―21 Establishment and validation of a drug-target microarray for SARS-CoV-2 Peng Chen, Zehua Zeng, Hongwu Du
84 [GO] 2020―Jul―14 Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus Yohei Takeda, Hiroshi Uchiumi, Sachiko Matsuda, Haruko Ogawa
85 [GO] 2020―Jun―20 SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine Prabhat Pratap Singh Tomar, Isaiah T. Arkin
86 [GO] 2020―Jun―16 Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein Haiyang Zhang, Jialu Tu, Chulei Cao, Ting Yang, Liangcai Gao
87 [GO] 2020―Jun―09 Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, et al. (+8)
88 [GO] 2020―Jun―08 Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents Lalu Muhammad Irham, Wan-Hsuan Chou, Marcus J. Calkins, Wirawan Adikusuma, Shie-Liang Hsieh, Wei-Chiao Chang
89 [GO] 2020―May―29 Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke Choi Ji-Young, Lee Hye-Kyung, Park Jung Hyun, Cho Sun-Jung, Kwon Munjin, Jo Chulman, Koh Young Ho
90 [GO] 2020―May―14 Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism Houcemeddine Othman, Zied Bouslama, Jean-Tristan Brandenburg, Jorge da Rocha, Yosr Hamdi, Kais Ghedira, et al. (+2)
91 [GO] 2020―May―06 Stability of RNA sequences derived from the coronavirus genome in human cells Hiroyasu Wakida, Kentaro Kawata, Yuta Yamaji, Emi Hattori, Takaho Tsuchiya, Youichiro Wada, et al. (+2)
92 [GO] 2020―Apr―30 Biochemical characterization of SARS-CoV-2 nucleocapsid protein Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, et al. (+10)
93 [GO] 2020―Apr―09 A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization Pietro Bongini, Alfonso Trezza, Monica Bianchini, Ottavia Spiga, Neri Niccolai
94 [GO] 2020―Mar―19 Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Furong Qi, Shen Qian, Shuye Zhang, Zheng Zhang
95 [GO] 2020―Mar―19 Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection Junwen Luan, Yue Lu, Xiaolu Jin, Leiliang Zhang
96 [GO] 2020―Feb―17 Structure analysis of the receptor binding of 2019-nCoV Yun Chen, Yao Guo, Yihang Pan, Zhizhuang Joe Zhao


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec